Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • secda1
    Junior Member
    • Jun 2012
    • 8

    #1

    comments on "Partek Flow" ?

    Hi all,

    I was just wondering if anybody had tried the new software from Partek: "Partek flow" for differential gene expression?
    And the pros/cons it had versus the usual software such as cufflinks, EdgeR, DeSeq ... ?

    Cheers
  • Weipingchen
    Junior Member
    • Aug 2012
    • 2

    #2
    About Parteck Flow's GSA

    Hi there, Greetings. Our core facility is using Partek Genomics Suite, and I’ve tried Partek Flow's GSA (Gene Specific Analysis) for differential gene expression and I think this may be by far the best out there for my limited knowledge for followings: First of all, it tests for log normal, Poisson, negative binomial, zero-inflated Poisson, and zero-inflated negative binomial for each gene which is especially helpful for analyzing clinical related data. Second, it checks multiple factors for each gene (e.g. tumor status, gender, etc.) to see which factors are influencing that particular gene. It thus has at lease two obvious benefits: A) it increased power due to better model fit, and B) it may help us to learn more about the biology, such as, which factors are influencing your gene expression in your experimental designs. All of the other algorithms you mentioned assume that there is only one single distribution apply to all genes and that all genes are influenced by the same factor, which may not be true in a lot of cases. In addition, Partek Flow's GSA can handle any number of factors. Many of the public domain algorithms seems to handle only one factor. I hope above may help parts of your questions. Best, Weiping Chen.

    Comment

    • secda1
      Junior Member
      • Jun 2012
      • 8

      #3
      Hi,

      Thanks for all the infos. One more question: would you then recommend using Partek Flow with the Gene specific analysis tool rather than the "normal" Genomic suite ?

      Comment

      • Weipingchen
        Junior Member
        • Aug 2012
        • 2

        #4
        Hi,
        This is a good question. I have asked the similar question when I was introduced to the Partek Flow. I think that Partek Flow is a just new web-based product that makes use of multiple CPU's which is useful for compute-intensive tasks often encountered in NGS data. It provides various annotations for various purposes or from databases. Partek's Genomics Suite has a bigger suite of downstream analysis statistical tools, but it does not have the GSA. So I think this may be case dependent, it depends on what type of analysis is most important for you. We use Partek Genomics Suite a lot for the downstream analysis and visualization for both Microarray and NGS data in our core lab daily, such as clustering, pathways and gene ontologies, etc. I just started to work on raw sequencing data from different platforms by Partek Flow for re-annotation purpose and etc. I think system biologist would love to have it for looking the sequence data again from ways with new questions which is Genomics Suite may not have in term of with new annotation from a new database and etc. You may then use the Genomics Suite to analysis the results again from the Flow. Best.
        Last edited by Weipingchen; 08-24-2012, 05:23 AM.

        Comment

        • Luke97
          Junior Member
          • Oct 2012
          • 1

          #5
          Hi, I used Partek Flow and this product was not that great and very expensive for the current features available on the product. It seems this product is not ready for the market yet, to many problems. I used CLC Bio with excellent results and they now give full local support across Europe.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            Yesterday, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 05:39 AM
          0 responses
          14 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-13-2026, 09:56 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-09-2026, 11:14 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 09-29-2026, 09:51 AM
          0 responses
          78 views
          0 reactions
          Last Post SEQadmin2  
          Working...